Prevalence of methicillin and vancomycin-resistant Staphylococcus aureus in goat meat and environment of sales in Uyo metropolis, Akwa Ibom State, Nigeria
Barre latérale de l'article
Contenu principal de l'article
Résumé
Background: There has been an increasing incidence of drug resistance associated with Methicillin-Resistant Staphylococcus aureus (MRSA) and the emergence of vancomycin resistance trait in humans leading to concerns to detect other sources which this resistant could emanate. This study was carried out to determine the prevalence, antibiotic susceptibility profile of MRSA and vancomycin-resistant Staphylococcus aureus (VRSA) in goat meat, its handlers and environment of sales within Uyo Metropolis, Akwa Ibom State.
Methods: Staphylococcus aureus were isolated from the samples using mannitol salt agar (MSA) and standard laboratory methods. Antibiotic susceptibility pattern was determined using modified Kirby Bauer disc agar diffusion method.
Results: Ninety-five (63.3%) isolates out of the 150 samples were confirmed and characterized as Staphylococcus aureus. One hundred percent (100 %) of the isolates were resistant to norfloxacin (10 µg), One hundred percent (100 %) were susceptible to rifampicin (20 µg) and levofloxacin (20 µg) respectively. Fifty-two (54.7 %) of the isolates were MRSA. The multiple antibiotics resistance (MAR) index indicated that 39 (75 %) were resistant to 3 or more antibiotics (MARI ? 3). Further PCR analysis of Staphylococcus aureus isolates that were MRSA indicated the presence of mecA gene in all the samples screened. There was a hundred percent (100 %) susceptibility of confirmed MRSA to vancomycin.
Conclusion: Goat meat, its environment of slaughter and sales in Uyo metropolis were confirmed a reservoir of Methicillin-Resistant Staphylococcus aureus (MRSA) but not of Vancomycin-Resistant Staphylococcus aureus (VRSA).
Téléchargements
Renseignements sur l'article
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
Références
0 REFERENCES
Abraham, E. P. and Chain, E. An enzyme from bacteria able to destroy penicillin. Journal of Infectious Diseases 2008; 10: 677-678.
Azeez-Akande, O., Utosala, S. J. and Epoke, J. Distribution and antibiotic susceptibility pattern of Methicillin Resistant Staphylococcus aureus isolates in University Teaching Hospital in Nigeria. Sahel Medical Journal 2008; 11(4): 142-147.
Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T., Tenover, F. C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin C susceptibility. Journal of Antimicrobial Chemotherapy 1997; 40:135–136. .
Shariati, A., Dadashi, M., Moghadam, M.T., Van Belkum, A., Yaslianifard, S. and Darban-Sarokhalil, D. Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis. Scientific Reports 2020; 10(1):12689.
Smith, K. E., Besser, J. M., Hedberg, C. W., Leano, F. T., Bender, J. B. and Wicklund, J. H. Quinolone-resistant Campylobacter jejuni Infections in Minnesota, 1992-1998. Investigation Team. The New England Journal of Medicine 1999; 340(20):1525-1532.
Howden, B. P., Johnson, P. D., Ward, P. B., Stinear, T. P. and Davies, J. K. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Journal of Antimicrobial Agents Chemotherapy 2006; 50(9):3039-47.
Meek, R. W., Vyas, H. and Piddock, L. J. V. Non-medical Uses of antibiotics: Time to Restrict Their Use? Journal of Public Library of Science Biology 2015; 13(10): e1002266
Cheesbrough, M. Medical laboratory manual for tropical countries. Microbiology. Cambridge University Press 2000; 2: 62-70.
Cappuccino, J. G. and Sherman, N. Microbiology a Laboratory Manual. (5th edn). Menlo Park, (CA): The Benjamin/Cummings Publishing Company Incorporated, San Francisco 1996.
Paul, S., Bezbaruah, R. L., Roy, M. K. and Ghosh, A. C. Multiple antibiotic resistance (MAR) index and its reversion in Pseudomonas aeruginosa. Letters in applied microbiology 1997; 24(3), 169–171.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fourth Informational Supplement. CLSI Document M100-S24,Wayne 2014; 34(1).
Kaiser, M. L, Thompson, D. J., Malinoski, D., Lane. C. and Cinat, M. E. Epidermiology and risk factors for hospital-acquired methicillin resistant Staphylococcus aureus among burn patients. Journal of Burn Care 2011; 32(3): 429–434.
Schweizer, M., Ward, M., Cobb, S., McDanel, J., Leder, L. and Wibbenmeyer, L. The epidemiology of methicillin-resistant Staphylococcus aureus on a burn trauma unit. Infectious Control Hospital Epidemiology 2012; 33(11): 1118–1125.
Chambers, H. F. Community-associated MRSA-Resistance and virulence converge. New England Journal of Medicine 2005; 352(14):1485-7.
Klevens, R. M, Morrison, M. A., Nadle, J., Petit, S. and Gershman, K. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of American Medical Association 2007; 298:1763–1771.
Tallent, S. M., Bischoff, T., Climo, M., Ostrowsky, B., Wenzel, R. P. and Edmond, M. B. Vancomycin susceptibility of oxacillin resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections. Journal of Clinical Microbiology 2002; 40(6):22-49.
Arumugam, G., Periasamy, H. and Maneesh, P. Staphylococcus aureus: Overview of Bacteriology, Clinical Diseases, Epidemiology, Antibiotic Resistance and Therapeutic Approach, Frontiers in Staphylococcus aureus. IntechOpen 2017.
Chien, J. W., Kucia, M. L., Salata, R. A. Use of linezolid, an oxa¬zolidinone, in the treatment of multidrug-resistant Gram-positive bacterial infections. Clinical Infectious Diseases 2000; 30:146-151.
Karuniawati, H., Hassali, M. A. A., Ismail, W. I., Taufik, T., and Suryawati, S. Antibiotic use in animal husbandry: A mixed-methods study among general community in Boyolali, Indonesia. International Journal of One Health 2021; 7(1):122-127.
Abdulkadir, A., Kabir, J., Bello, M., and Olayinka, B. Prevalence Study of Methicillin Resistant Staphylococcus aureus and it SCCmec Features in Horses and Handlers in Zaria and Kaduna, Nigeria. Nigerian Veterinary Journal 2022; 43(3):54-68.
Sahebnasagh, R., Saderi, H. and Owlia, P. The prevalence of resistance to methicillin in Staphylococcus aureus strains isolated from patients by PCR method for detection of meca and nuc genes. Iranian Journal of Public Health 2014; 43(1), 84–92.
Jain, A., Agarwal, A. and Verma, R. K. Cefoxitin disc diffusion test for detection of methicillin-resistant staphylococci. Journal of Medical Microbiology 2008; 57(8), 957–961.
Kloska, F., Beyerbach, M. and Klien, G. Infection Dynamics and Antimicrobial Resistance Profile of Salmonella paratyphi B d-tartrate Positive (Java) in a persistently Infected Broiler Barn. Internationl Journal of Environmental research and Public Health 2017; 14(1): 101-107.
Emmerson, A. M. and Jones, A. M. The quinolones: decades of development and use. Journal of Antimicrobial Chemotherapy 2003; 51(1):13-20.
Okoye, E. B., Omeje, M. J. and Ugwuoji, E. T. Detection and Prevalence of Methicillin and Vancomycin Resistant Staphylococcus aureus among Clinical Isolates in ESUTH, Enugu State, Nigeria. Journal of Current Biomedical Research 2022; 2(2):170-186.
Ibadin, E. E., Enabulele, I. O. and Muinah, F. Prevalence of mecA gene among staphylococci from clinical samples of a tertiary hospital in Benin City, Nigeria. African Health Sciences 2017; 17(4), 1000– 1010.
Onemu, O. S. and Ophori, E. A. Prevalence of multi-drug resistant Staphylococcus aureus in clinical specimens obtained from patients attending the University of Benin teaching Hospital, Benin City, Nigeria. Journal of National Science Research 2013; 3(5):154-9.
Adeiza, S. S., Onaolapo, J. A. and Olayinka, B. O. (2020). Prevalence, risk-factors and antimicrobial susceptibility profile of methicillin-resistant Staphylococcus aureus (MRSA) obtained from nares of patients and staff of Sokoto state-owned hospitals in Nigeria. German Medical Science hygiene and infection control 2020; 15, ISSN 2196-5226.
Abubakar, U. and Sulaiman, S. Prevalence, trend and antimicrobial susceptibility of Methicillin Resistant Staphylococcus aureus in Nigeria: a systematic review. Journal of Infection and Public Health 2018; 11(6), 763–770.
Nwankwo, E. O., Mofolorunsho, C, K. and Akande, A. O. Aetiological agents of surgical site infection in a specialist hospital in Kano, north-western Nigeria. Tanzania Journal of Health Research 2014; 16(4), 289–295.
Nwankwo, B. O., Abdulhadi, S., Magagi, A. and Ihesiulor, G. Methicillin-resistant Staphylococcus aureus and their antibiotic susceptibility pattern in Kano, Nigeria. African Journal of Clinical Experimental Microbiology 2010; 11(1):1595-689.
Otobo, U. N., Wala, P. G. and Agbagwa, O. E. Occurrence of Vancomycin-Resistant Staphylococcus aureus (VRSA) in Clinical and Community Isolates within the University of Port Harcourt. Advances in Biotechnology and Microbiology. 2018; 11(4):555816.